UK Boy Receives Groundbreaking Brain Implant for Severe Epilepsy

The innovative device has reduced 13-year-old Oran Knowlson's seizures by 80%, offering new hope for treatment-resistant epilepsy.

Oran Knowlson is the first patient to receive the implant as part of a UK clinical trial.
The device, embedded in the skull, delivers electrical pulses to block seizures.
Oran's quality of life has improved significantly, allowing him to take up new activities.
Traditional treatments for Oran's type of epilepsy were ineffective, necessitating this new approach.
The trial will expand to include more patients, aiming to establish a new standard for epilepsy treatment.